PL2555789T3 - Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowania - Google Patents
Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowaniaInfo
- Publication number
- PL2555789T3 PL2555789T3 PL11718957T PL11718957T PL2555789T3 PL 2555789 T3 PL2555789 T3 PL 2555789T3 PL 11718957 T PL11718957 T PL 11718957T PL 11718957 T PL11718957 T PL 11718957T PL 2555789 T3 PL2555789 T3 PL 2555789T3
- Authority
- PL
- Poland
- Prior art keywords
- trem
- tlt
- transcript
- peptides derived
- inhibiting peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10305364 | 2010-04-08 | ||
| EP11718957.1A EP2555789B1 (en) | 2010-04-08 | 2011-04-08 | Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof |
| PCT/EP2011/055519 WO2011124685A1 (en) | 2010-04-08 | 2011-04-08 | Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2555789T3 true PL2555789T3 (pl) | 2021-02-08 |
Family
ID=42262363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11718957T PL2555789T3 (pl) | 2010-04-08 | 2011-04-08 | Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowania |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9255136B2 (pl) |
| EP (2) | EP3741383A1 (pl) |
| JP (2) | JP5918750B2 (pl) |
| CN (1) | CN103153327B (pl) |
| AU (1) | AU2011237851B2 (pl) |
| CA (1) | CA2795390C (pl) |
| CY (1) | CY1123304T1 (pl) |
| DK (1) | DK2555789T3 (pl) |
| ES (1) | ES2805301T3 (pl) |
| HR (1) | HRP20201081T1 (pl) |
| HU (1) | HUE050815T2 (pl) |
| LT (1) | LT2555789T (pl) |
| NZ (1) | NZ602845A (pl) |
| PL (1) | PL2555789T3 (pl) |
| PT (1) | PT2555789T (pl) |
| RS (1) | RS60636B1 (pl) |
| SI (1) | SI2555789T1 (pl) |
| WO (1) | WO2011124685A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015002994A (es) | 2012-09-07 | 2016-01-14 | Inserm Inst Nat De La Santé Et De La Rech Médicale | Peptidos de inhibidores obtenidos del receptor desencadenante expresado en celulas mieloides de tipo 1 (trem-1) y transcrito similar a trem 1 (tlt-1) y usos de los mismos. |
| KR101404098B1 (ko) * | 2012-11-29 | 2014-06-05 | 성균관대학교산학협력단 | 금속 나노와이어-유기화합물 복합체, 이를 포함하는 필름, 및 이의 제조 방법 |
| CN108135961A (zh) * | 2015-06-12 | 2018-06-08 | 台湾基督长老教会马偕医疗财团法人马偕纪念医院 | 调控免疫反应的方法及多肽 |
| JOP20190248A1 (ar) | 2017-04-21 | 2019-10-20 | Amgen Inc | بروتينات ربط مولد ضد trem2 واستخداماته |
| CN108276488B (zh) * | 2018-01-26 | 2020-06-19 | 四川农业大学 | 一种鸡髓样细胞触发受体b2多克隆抗体及其制备方法和应用 |
| EP3836951A1 (en) | 2018-08-13 | 2021-06-23 | Signablok, Inc. | Peptides and compositions for targeted treatment and imaging |
| CA3114503A1 (en) * | 2018-09-28 | 2020-04-02 | Inotrem | Use of soluble trem-1 levels for identifying subjects susceptible to respond to an anti-inflammatory therapy |
| EP3956359A1 (en) | 2019-04-17 | 2022-02-23 | Novo Nordisk A/S | Bispecific antibodies |
| CN114945580B (zh) * | 2020-01-15 | 2023-12-15 | 北京费森尤斯卡比医药有限公司 | 用于合成南吉博肽的方法 |
| US20230330222A1 (en) * | 2020-05-14 | 2023-10-19 | Ascendo Biotechnology, Inc. | Selective targeting of the treml1/md2 interaction by small peptide or protein and its use for vaccine adjuvants |
| CN116490199A (zh) * | 2020-06-05 | 2023-07-25 | 伊诺特伦公司 | 用于治疗患有冠状病毒感染的受试者的trem-1抑制剂 |
| JP2024521904A (ja) | 2021-06-02 | 2024-06-04 | イノトレム | 抗ｔｒｅｍ－１抗体 |
| CN113755580B (zh) * | 2021-09-13 | 2023-10-27 | 中国医学科学院阜外医院 | 一种治疗和/或缓解淋巴水肿的药物干预靶点及其应用 |
| CN118359676A (zh) * | 2023-01-19 | 2024-07-19 | 武汉人福创新药物研发中心有限公司 | 作为Trem-1抑制剂的修饰肽 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2005261A (en) | 1933-05-24 | 1935-06-18 | Leland Electric Co | Riveting machine |
| US4861719A (en) | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
| US5278056A (en) | 1988-02-05 | 1994-01-11 | The Trustees Of Columbia University In The City Of New York | Retroviral packaging cell lines and process of using same |
| US5670488A (en) | 1992-12-03 | 1997-09-23 | Genzyme Corporation | Adenovirus vector for gene therapy |
| EP1493825A3 (en) | 1990-06-11 | 2005-02-09 | Gilead Sciences, Inc. | Method for producing nucleic acid ligands |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| DE69434860T2 (de) | 1993-02-22 | 2007-03-15 | The Rockefeller University | Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion |
| FR2712812B1 (fr) | 1993-11-23 | 1996-02-09 | Centre Nat Rech Scient | Composition pour la production de produits thérapeutiques in vivo. |
| IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| US7129072B1 (en) | 1999-08-30 | 2006-10-31 | New York University | Crystal of fibroblast growth factor receptor 1 in complex with fibroblast growth factor |
| WO2001043695A2 (en) | 1999-10-27 | 2001-06-21 | Cel-Sci Corporation | Peptide constructs for treating autoimmune and related diseases |
| JP2001210726A (ja) * | 2000-01-24 | 2001-08-03 | Hitachi Ltd | 半導体装置及びその製造方法 |
| AU6173501A (en) * | 2000-05-19 | 2001-12-03 | Blood Res Center | Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
| CA2409996C (en) | 2000-05-23 | 2016-03-01 | Cenes Pharmaceuticals, Inc. | Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| US20040266674A1 (en) * | 2001-09-05 | 2004-12-30 | Mills Bradley Jay | Lp mammalian proteins; related reagents |
| US20040180409A1 (en) * | 2003-03-16 | 2004-09-16 | Mcvicar Daniel | TLT-1, a novel platelet-associated receptor and uses therefor |
| GB0426146D0 (en) * | 2004-11-29 | 2004-12-29 | Bioxell Spa | Therapeutic peptides and method |
| US20130332133A1 (en) | 2006-05-11 | 2013-12-12 | Ramot At Tel Aviv University Ltd. | Classification of Protein Sequences and Uses of Classified Proteins |
| US7553936B2 (en) * | 2006-12-04 | 2009-06-30 | The United States of America as represented by Secretary Department of Health and Human Services | Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions |
| WO2010132370A2 (en) | 2009-05-11 | 2010-11-18 | Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Soluble tlt-1 for the treatment and diagnosis of sepsis |
-
2011
- 2011-04-08 PL PL11718957T patent/PL2555789T3/pl unknown
- 2011-04-08 RS RS20200808A patent/RS60636B1/sr unknown
- 2011-04-08 PT PT117189571T patent/PT2555789T/pt unknown
- 2011-04-08 EP EP20176938.7A patent/EP3741383A1/en not_active Withdrawn
- 2011-04-08 DK DK11718957.1T patent/DK2555789T3/da active
- 2011-04-08 HU HUE11718957A patent/HUE050815T2/hu unknown
- 2011-04-08 US US13/639,374 patent/US9255136B2/en active Active
- 2011-04-08 JP JP2013503130A patent/JP5918750B2/ja active Active
- 2011-04-08 AU AU2011237851A patent/AU2011237851B2/en active Active
- 2011-04-08 EP EP11718957.1A patent/EP2555789B1/en active Active
- 2011-04-08 CN CN201180028906.9A patent/CN103153327B/zh active Active
- 2011-04-08 SI SI201131893T patent/SI2555789T1/sl unknown
- 2011-04-08 NZ NZ602845A patent/NZ602845A/en unknown
- 2011-04-08 ES ES11718957T patent/ES2805301T3/es active Active
- 2011-04-08 CA CA2795390A patent/CA2795390C/en active Active
- 2011-04-08 LT LTEP11718957.1T patent/LT2555789T/lt unknown
- 2011-04-08 WO PCT/EP2011/055519 patent/WO2011124685A1/en active Application Filing
-
2015
- 2015-04-29 US US14/699,620 patent/US9815883B2/en active Active
-
2016
- 2016-02-19 JP JP2016029659A patent/JP2016169208A/ja active Pending
-
2020
- 2020-07-09 HR HRP20201081TT patent/HRP20201081T1/hr unknown
- 2020-07-10 CY CY20201100636T patent/CY1123304T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2555789A1 (en) | 2013-02-13 |
| AU2011237851A1 (en) | 2012-11-01 |
| HUE050815T2 (hu) | 2021-01-28 |
| HRP20201081T1 (hr) | 2021-01-22 |
| JP2013523140A (ja) | 2013-06-17 |
| CN103153327A (zh) | 2013-06-12 |
| CA2795390C (en) | 2020-11-03 |
| AU2011237851B2 (en) | 2015-02-05 |
| CN103153327B (zh) | 2016-01-20 |
| US9255136B2 (en) | 2016-02-09 |
| ES2805301T3 (es) | 2021-02-11 |
| JP5918750B2 (ja) | 2016-05-18 |
| RS60636B1 (sr) | 2020-09-30 |
| DK2555789T3 (da) | 2020-07-20 |
| CY1123304T1 (el) | 2021-12-31 |
| JP2016169208A (ja) | 2016-09-23 |
| SI2555789T1 (sl) | 2020-10-30 |
| WO2011124685A1 (en) | 2011-10-13 |
| US9815883B2 (en) | 2017-11-14 |
| EP2555789B1 (en) | 2020-06-10 |
| PT2555789T (pt) | 2020-07-14 |
| US20130029921A1 (en) | 2013-01-31 |
| NZ602845A (en) | 2015-05-29 |
| US20160015773A1 (en) | 2016-01-21 |
| EP3741383A1 (en) | 2020-11-25 |
| CA2795390A1 (en) | 2011-10-13 |
| LT2555789T (lt) | 2020-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS60636B1 (sr) | Inhibitorni peptidi poreklom od trem-sličnog transkripta 1 (tlt-1) i njihove upotrebe | |
| HK1208686A1 (en) | Aromatic-cationic peptides and uses of same | |
| IL248880A0 (en) | Preparations containing r-g-cysteic acid peptides and their uses | |
| EP2566880A4 (en) | AROMATIC-CATIONIC PEPTIDES AND USES THEREOF | |
| PL2588491T3 (pl) | Nowy peptyd i jego zastosowanie | |
| EP2383283A4 (en) | NOGGIN PEPTIDE AND ITS USE | |
| EP2313498A4 (en) | DETECTION SEQUENCES FOR MEGANUCLEASES FROM I-CREI AND ITS USE | |
| EP2593595A4 (en) | NOVEL PEPTIDES AND USES THEREOF | |
| EP2474555A4 (en) | PEPTIDE DERIVED FROM WNT10 AND USE THEREOF | |
| GB201012651D0 (en) | Peptides | |
| EP2521564A4 (en) | APOE PEPTIDE DIMERS AND USES THEREOF | |
| EP2513137A4 (en) | PEPTIDES DERIVED FROM SAPOSINE-A AND USES THEREOF | |
| EP2793921A4 (en) | PEPTIDES DERIVED FROM SAPOSIN A AND USES THEREOF | |
| EP2471553A4 (en) | IMMUNOGENIC COMPOSITION WITH PEPTIDES FROM CYTOMEGALOVIRUS AND THEIR USE | |
| PL2627668T3 (pl) | Peptydy i ich zastosowanie | |
| PL3346273T3 (pl) | Nowe, pochodzące od d3 d-enancjomeryczne peptydy i ich zastosowanie | |
| HK1168363A1 (en) | Novel peptide and use thereof | |
| IL213026A0 (en) | TNA-a INHIBITING PEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | |
| EP2285827A4 (en) | PEPTIDES AND ITS USE | |
| IL225464A0 (en) | 2nd peptides, preparations containing them and their uses | |
| IL216199A (en) | A peptide containing the sequence ednimvtfrnqasr | |
| EP2627674A4 (en) | EGFR BASED PEPTIDES | |
| SG173752A1 (en) | Modifications of cupredoxin derived peptides and methods of use thereof | |
| EP2358740A4 (en) | CYCLIC PEPTIDES AND USES THEREOF | |
| IL225405A0 (en) | Methods for immune modulation and systems for the treatment and/or prevention of atherosclerosis, proteins, peptides and preparations. |